Stocks and Investing Stocks and Investing
Mon, October 7, 2024
Fri, October 4, 2024

Gregory Renza Maintained (VRCA) at Buy with Decreased Target to $11 on, Oct 4th, 2024


Published on 2024-10-28 14:39:41 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Buy with Decreased Target from $13 to $11 on, Oct 4th, 2024.

Gregory has made no other calls on VRCA in the last 4 months.



There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, all agree with Gregory's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Serge Belanger of "Needham" Downgraded from Strong Buy to Hold and Held Target at $12 on, Thursday, October 3rd, 2024
  • Kemp Dolliver of "Brookline Capital" Downgraded from Strong Buy to Hold on, Wednesday, October 2nd, 2024
Contributing Sources